Status:
COMPLETED
Uric Acid Study in Healthy Male Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Gout
Coronary Artery Disease
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
This study is being conducted to examine the effect of AZD6140 on the levels of certain chemicals in subjects' blood and urine.
Eligibility Criteria
Inclusion
- Normal physical examination, vital signs, electrocardiogram (ECG) and laboratory values (unless the investigator considers an abnormality not to be clinically significant)
- Normal laboratory tests at screening
- Non-smoker (no cigarette/tobacco use for at least 6 months)
Exclusion
- Personal or family history of gout, gouty arthritis, or renal stones
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00738842
Start Date
May 1 2008
End Date
July 1 2008
Last Update
December 3 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.